A detailed history of Oracle Alpha Inc. transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Oracle Alpha Inc. holds 19,482 shares of RPTX stock, worth $26,300. This represents 0.16% of its overall portfolio holdings.

Number of Shares
19,482
Previous 12,288 58.54%
Holding current value
$26,300
Previous $89.7 Million 2.29%
% of portfolio
0.16%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$4.53 - $8.41 $32,588 - $60,501
7,194 Added 58.54%
19,482 $91.8 Million
Q4 2023

Feb 14, 2024

BUY
$3.22 - $11.79 $39,567 - $144,875
12,288 New
12,288 $89.7 Million

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $56.6M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Oracle Alpha Inc. Portfolio

Follow Oracle Alpha Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Alpha Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oracle Alpha Inc. with notifications on news.